Yahoo MoviesFantasy Basketball Pickups - Unleash Saddiq!
Yahoo Fantasy basketball analyst Dalton Del Don offers his three pickups for the week including the Pistons forward in line for an expanded workload.
Yahoo Fantasy basketball analyst Dalton Del Don offers his three pickups for the week including the Pistons forward in line for an expanded workload.
Novavax (NVAX) is hoping its trial data from the United Kingdom and South Africa can be aggregated and used to apply for an emergency use authorization (EAU) in the U.S. to help expedite the rollout of its COVID-19 vaccine.
Starting in March, the HGreg Group’s 30 North American stores in Canada and the United States, will accept cryptocurrency payments for the purchase of new and pre-owned vehicles.
Artificial intelligence chip designer Wave Computing Inc said on Monday it has emerged from Chapter 11 bankruptcy protection following an auction of the company and will rebrand the firm as MIPS. The company traces its origins back to MIPS Computer Systems Inc, cofounded more than 35 years ago by Stanford University professor John Hennessy, who is now chairman of Alphabet Inc. MIPS was the commercial home of an earlier academic effort to create an architecture for computer processors that remain in wide use today by firms such as Intel Corp's Mobileye self-driving car unit. Wave Computing filed for bankruptcy in April.
Kennedy Wilson, Inc. ("Kennedy Wilson"), a wholly owned subsidiary of global real estate investment company Kennedy-Wilson Holdings, Inc. (NYSE:KW), today announced the pricing of its offering of $100 million aggregate principal amount of 4.75% senior notes due 2029 (the "2029 notes") and $100 million aggregate principal amount of 5.00% senior notes due 2031 (the "2031 notes" and, together with the 2029 notes, the "notes"). The offering size was increased from the previously announced offering size of $150 million aggregate principal amount of notes. The notes will be issued as additional notes under the indentures pursuant to which Kennedy Wilson previously issued $500 million aggregate principal amount of 4.75% senior notes due 2029 and $500 million aggregate principal amount of 5.00% senior notes due 2031 (together, the "initial notes"). Each series of notes will be treated as a single series of securities with its corresponding series of initial notes under the applicable indenture and will have the same CUSIP number as, and be fungible with, the applicable series of the initial notes. Closing of the offering is expected to occur on March 15, 2021. The 2029 notes will be issued at an offering price of 102.250% of their face amount and the 2031 notes will be issued at an offering price of 102.000% of their face amount.
Lord Hague said some business and personal taxes would ‘have to go up’ due to the current economic climate.
Matthew Modine is pulling off a college admissions scandal in a new trailer for the Netflix documentary Operation Varity Blues (premiering Wednesday, March 17). The Stranger Things actor plays Rick Singer, the man behind the scheme, in the doc, which uses an “innovative combination of interviews and narrative recreations of the FBI’s wiretapped conversations between […]
XHR earnings call for the period ending December 31, 2020.
These days, finding Canadian value stocks are few and far between. This top long-term gold stock, however, is trading at a major bargain. The post Canadian Value Stocks: This Gold Stock Is a Screaming Buy! appeared first on The Motley Fool Canada.
WASHINGTON — President Joe Biden met virtually Monday with Mexican President Andrés Manuel López Obrador — a chance for the pair to talk more fully about migration, confronting the coronavirus and co-operating on economic and national security issues. “This is what I know, the United States and Mexico are stronger when we stand together,” Biden told López Obrador at the outset of the meeting, alluding to past differences between the two countries. “We’re safer when we work together. Whether it’s addressing the challenges of our shared border, or getting this pandemic under control.” Mexico's president had said he intends during the meeting to propose to Biden a new immigrant labour program that could bring 600,000 to 800,000 Mexican and Central American immigrants a year to work legally in the United States. A senior Biden administration official declined to say whether the U.S. president would back or oppose the proposal, saying only that both countries agree on the need to expand legal pathways for migration. The official insisted on anonymity to discuss private conversations. Asked about the Mexican president’s proposal. White House press secretary Jen Psaki said that reinstituting the Bracero program would require action by Congress. The original “Bracero” program allowed Mexicans to work temporarily in the United States to fill labour shortages during World War II and for a couple of decades after the war. López Obrador said the U.S. economy needs Mexican workers because of “their strength, their youth.” On Monday, López Obrador said his new proposal would be a program not only for agriculture workers but for other sectors and professionals. The White House also signalled that Biden was not willing to budge on another López Obrador request — to send U.S. manufactured coronavirus vaccines to his country. Psaki said Biden would not agree to the move, saying the president was first focused on getting Americans vaccinated. A similar posture toward Canada has also proved to be a wrinkle in that relationship. The Biden official said the meeting will help Biden begin to institutionalize the relationship with Mexico, rather than let it be determined by tweets — a preferred form of diplomacy by his predecessor, Donald Trump. The United States shares a trade agreement — most recently updated in 2018 and 2019 — with Mexico and Canada, which are its second- and third-biggest trade partners after China. The trade agreement could complicate López Obrador's efforts to possibly defund and eliminate independent regulatory, watchdog and transparency agencies in Mexico. There are also questions of whether López Obrador will warm to Biden's efforts to address climate change and move to cleaner energy sources. The Mexican president supports a measure to make that country's national grids prioritize power from government plants, many of which burn coal or fuel oil. At Monday's news conference, López Obrador confirmed they would discuss climate change, but he said “Biden is respectful of our sovereignty” because “he doesn’t see Mexico as America’s backyard." The Trump era was defined by the threat of tariffs, crackdowns on migration and his desire to construct a wall on the U.S. southern border, yet Trump appeared to enjoy an amicable relationship with his Mexican counterpart. Mexico paid nothing for Trump’s cherished border wall, despite the U.S. leader’s repeated claims that it would. But López Obrador’s government did send troops to Mexico’s southern border with Guatemala to deal with an unprecedented wave of asylum-seekers bound for the U.S. Mexico hosted about 70,000 people seeking U.S. asylum while they waited for dates in immigration courts, a policy known as Remain in Mexico and officially as Migrant Protection Protocols. The Biden administration immediately began to unwind Remain in Mexico, suspending it for new arrivals on the president’s first day in office and soon after announcing that an estimated 26,000 people with still-active cases could be released in the United States while their cases played out. But Biden, through the U.S. Centers for Disease Control and Prevention, has kept extraordinary pandemic-related powers in place to immediately expel anyone arriving at the U.S. border from Mexico without an opportunity to seek asylum. Mexicans and many Central Americans are typically returned to Mexico in less than two hours under Title 42 authority — so named for a section of a 1944 public health law. Biden aides have signalled they have no immediate plans to lift it. Yet Biden has also shown an openness to immigrants who previously came to the country illegally. He is backing a bill to give legal status and a path to citizenship to all of the estimated 11 million people in the country who don’t have it. Biden also broke with Trump by supporting efforts to allow hundreds of thousands of people who came to the U.S. illegally as young children to remain in the country. López Obrador said Saturday that an aging United States will also need temporary immigrant workers from Mexico to sustain economic growth. He said he plans to tell Biden, “It is better that we start putting order on migratory flows." But pressures are building at the U.S. southern border with an increase in children crossing into the country without visas. This has created a challenge for the Biden administration. Border Patrol agents are apprehending an average of more than 200 children crossing the border without a parent per day, but nearly all 7,100 beds for immigrant children maintained by the Department of Health and Human Services are full. Homeland Security Secretary Alejandro Mayorkas on Monday sought to push back against the notion that the crisis at the border was spinning out of control. “The men and women of the Department of Homeland Security, are working around the clock seven days a week to ensure that we do not have a crisis at the border, that we manage the challenge as acute as the challenge is, and they are not doing that alone,” Mayorkas said. The Biden administration has preserved a policy, imposed at the start of the COVID-19 outbreak, of quickly expelling people captured along the border and has tried to dissuade people from attempting the journey. Mayorkas, who is expected to take part in Monday's bilateral meeting, reiterated the administration's message to migrants that now is not the time to come to the United States. “We are not saying don’t come," Mayorkas said. “We are saying don’t come now." ___ Stevenson reported from Mexico City and Spagat from San Diego. Josh Boak, Mark Stevenson And Elliot Spagat, The Associated Press
Ladies and gentlemen, thank you for standing by, and welcome to the Itau Corpbanca Fourth Quarter 2020 Financial Results Conference Call. Thank you for joining our conference call for our fourth quarter 2020 financial results. This managerial financial model reflects how we measure, analyze and discuss financial results by segregating commercial performance, financial risk management, credit risk management, and cost efficiency.
It has over 1,300 five-star ratings and comes in five shades
Venti Technologies, the leader in safe-speed autonomous mobility, signs with PSA to automate cargo container movement among its Singapore terminals.
Heritage-Crystal Clean, Inc. (Nasdaq: HCCI), a leading provider of parts cleaning, hazardous and non-hazardous waste services, used oil re-refining, antifreeze recycling and field services primarily focused on small and mid-sized customers, today announced results for the fourth quarter of fiscal 2020 and for the full fiscal year, which ended January 2, 2021.
Today, Square, Inc. announced its industrial bank, Square Financial Services, has begun operations after completing the charter approval process with the Federal Deposit Insurance Corporation (FDIC) and the Utah Department of Financial Institutions.
Key Immunotherapy Drugs market participants include Sanofi S.A., F. Hoffmann-La Roche AG, Merck & Co., Inc., AstraZeneca plc, BioNTech SE, Gilead Sciences, Inc., Incyte Corporation, bluebird bio, Inc., and Genmab A/S, Bayer AGVancouver, British Columbia, March 01, 2021 (GLOBE NEWSWIRE) -- The global immunotherapy drugs market is projected to reach value of USD 365.57 Billion by 2027, according to a current analysis by Emergen Research. Throughout the forecast period, the global immunotherapy drugs market is expected to expand rapidly. This rapid growth of the immunotherapy drugs market is attributable to the rising advent of biologic drugs. Biologic drugs are intended to minimize inflammation and stop joint pain. Their use could be life-changing for several patients with autoimmune diseases. Moreover, the rising demand for monoclonal antibodies is projected to further drive the global immunotherapy drugs market during the forecast period. Furthermore, the surge in immunotherapy applications for treating chronic diseases is anticipated to fuel the immunotherapy drugs market during the forecast period. During the forecast period, the global immunotherapy drugs market can be hampered due to high prices of immunotherapy drugs. Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/417 Key Highlights of Report In April 2020, Forty-Seven, Inc. was acquired by Gilead Sciences, Inc. The acquisition would speed up the development of magrolimab as well as extend the tasks of Gilead in immuno-oncology.The autoimmune & inflammatory diseases segment is expected to expand considerably, at a CAGR of 12.2% during the forecast period. For a long time, immunotherapy is used to combat allergies, to mitigate implanted organ damage, and to minimize autoimmunity.The vaccine segment is expected to expand significantly during the forecast period. Cancer care vaccinations is a type of immunotherapy that treats cancer by strengthening the brain's normal immunity against cancer.Due to substantial research activities associated with cancer treatment utilizing immunotherapy drugs, the research centers segment is expected to expand significantly during the forecast periodDuring the forecast period, the Asia Pacific region is expected to expand rapidly in the near future. The increasing number of patients affected with cancer in the region is driving the market in the region.Key market participants include Sanofi S.A., F. Hoffmann-La Roche AG, Merck & Co., Inc., AstraZeneca plc, BioNTech SE, Gilead Sciences, Inc., Incyte Corporation, bluebird bio, Inc., and Genmab A/S, Bayer AG Check Our Prices@ https://www.emergenresearch.com/select-license/417Emergen Research has segmented the global immunotherapy drugs market on the basis of drug type, therapeutic area, end-user, and region. Drug Type Outlook (Revenue, USD Billion; 2017–2027) Checkpoint InhibitorsMonoclonal AntibodiesVaccinesInterleukinsInterferons Alpha and BetaOthers Therapeutic Area Outlook (Revenue, USD Billion; 2017–2027) Infectious DiseasesAutoimmune & Inflammatory DiseasesCancerOthers End-user Outlook (Revenue, USD Billion; 2017–2027) ClinicsResearch CentersHospitalsOthers Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/immunotherapy-drugs-market Regional Outlook (Revenue, USD Billion; 2017–2027) North America U.S.CanadaMexico Europe GermanyU.K.FranceBENELUXRest of Europe Asia Pacific ChinaJapanSouth KoreaIndiaRest of APAC Latin America BrazilRest of LATAM Middle East & Africa Saudi ArabiaUAERest of MEA Take a Look at our Related Reports: Topical Drug Delivery Market By Product Form (Semi-Solid, Solid Formulations, Transdermal Products, and Liquid Formulations), By Route (Dermal, Ophthalmic, Nasal, Others), By End-Use (Hospitals, Home Healthcare, Clinics, Diagnostic Centers, Burn Center), and By Regions Medical Smart Textiles Market By Technology (Textile Sensors, Wearable Technology), By Application (Surgery, Bio-Monitoring, Therapy, and Wellness), By End-use (Hospitals and Clinics, Medical Academic and Research Center), and By Region Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region Patient Registry Software Market By Delivery, By Database, By Registry Type, By Function, By Software Type (Integrated, Standalone), By End-use (Government & Third-Party Administrators, Pharmaceutical Companies, Hospitals, Research Centers, Others), and By Region, Forecast to 2027 Ambulatory EHR Market By Deployment (Cloud-based, On-premises), By Practice Size (Solo Practices, Large Practices, Small-medium-sized Practices), By Application, By End-use (Independent Centers, Hospital-owned Ambulatory Centers, Others), and By Region, Forecasts to 2027 About Emergen Research Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors. Contact Us: Eric Lee Corporate Sales Specialist Emergen Research | Web: www.emergenresearch.com Direct Line: +1 (604) 757-9756 E-mail: sales@emergenresearch.com Facebook | LinkedIn | Twitter | Blogs Read Full Press Release: https://www.emergenresearch.com/press-release/global-immunotherapy-drugs-market
WINNIPEG, Manitoba, March 01, 2021 (GLOBE NEWSWIRE) -- DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) ("Delta 9" or the "Company"), is pleased to announce that it has completed its final services milestone under an agreement with Ontario based Micro Cultivation partner, F1NE Cannabis Cultivation LTD. (“F1”). F1 is an arm’s length third party in which the Company has no ownership control or interest. As one of Delta 9’s Micro Cultivation partners, F1 entered into a Strategic Cooperation Agreement (“SCA”) with the company whereby Delta 9 provides services relating to the cannabis production, development of standard operating procedures and sanitation programs, consulting on Health Canada licensing, marketing services to develop the F1 brand and other services supporting the acquisition of the Health Canada license. On February 19, 2021, F1 confirmed it had reached its final milestone under the SCA and has been granted its cannabis micro cultivation licenses from Health Canada (the “Health Canada License”). “We are delighted that F1NE Cannabis Cultivation has received a Health Canada Licence for our proprietary and turn-key Grow Pod systems,” said John Arbuthnot, Founder and CEO of Delta 9. “Our turn key platform for Grow Pods and services continues to prove one of the best options for cannabis industry entrepreneurs seeking licensing and support services.” The Company's cannabis production methodology is based around a modular, scalable, and stackable production unit called a "Grow Pod", which are based on retrofitted 40-foot shipping containers. The turn key smart growing platforms are developed using precision hardware and software grow applications for the indoor cannabis cultivation marketplace. Delta 9 offers vertical growing units, integrated grow racks, and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and automated fertigation and watering systems. F1’s facility has been designed using this turn key and state of the art Grow Pod system. Once cultivation is harvested, Delta 9 plans to purchase the premium quality cannabis products from F1 for distribution through the Company's established distribution network, and through Delta 9's branded retail stores. Delta 9 has now successfully licensed over 100 Grow Pods in third party facilities across Canada. “F1NE Cannabis Cultivation is a privately owned boutique cannabis cultivator based in the Niagara Region of Ontario, close to dozens of wineries along the wine route to Niagara on the lake and the Horse Shoe Falls,” said Poncho Canna, President and CEO of F1NE Cannabis Cultivation. “Our goal is to produce the F1NEST quality cannabis product by bringing the legacy-market craft to a legal-market product.” F1 has developed a state-of-the-art micro cultivation facility on a one-and-a-half-acre parcel of land situated on Lake Ontario and beside some of the worlds best wine producers. F1 has applied and is expecting to receive a farm gate licence to sell their products directly to consumers traveling along the wine routes to Niagara on the lake and as part of the wine tours in the area. The facility includes some of the latest technology surrounding climate control and grow room automation. F1 expects this facility to be the first step in a more significant growth strategy, as it makes plans to double its production by growing a smaller plant that will leave room for two levels of cannabis production per Grow Pod. There are also plans in place to build an outdoor garden centre for customers to buy pots, grow mediums, lights and other items to grow like the pros. The well-rounded F1 Team has a strong entrepreneurial background, with an executive team that has many years experience of growing cannabis. The F1 Team is committed and passionate about growing premium craft cannabis and looks forward to rooting a leading craft cannabis company in Ontario. For more information contact: Investor & Media Contact:Ian Chadsey VP Corporate AffairsMobile: 204-898-7722E-mail: ian.chadsey@delta9.ca About Delta 9 Cannabis Inc. Delta 9 Cannabis Inc. is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. Delta 9's wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta 9's shares trade on the Toronto Stock Exchange under the symbol "DN" and on the OTCQX under the symbol "VRNDF". For more information, please visit www.delta9.ca. Disclaimer for Forward-Looking Information Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company's future business plans and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Forward looking statements in this news release include statements relating to: (i) F1's proposed micro cultivation operations; (ii) Delta 9's intention to sell F1's premium cannabis products; and (iii) Delta 9's development of micro cultivation services. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including F1’s cannabis production not being as anticipated, as well as all risk factors set forth in the annual information form of Delta 9 dated March 19, 2020 which has been filed on SEDAR. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. These forward-looking statements are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.
CEDAR RAPIDS, Iowa, March 01, 2021 (GLOBE NEWSWIRE) -- Management of United Fire Group, Inc. (Nasdaq: UFCS) ("UFG") will hold one-on-one meetings at the Association of Insurance and Financial Analysts (AIFA) Conference on Tuesday March 2, 2021. During the one-on-one meetings, management will present early estimates of some performance measures for first quarter of 2021. UFG's presentation for the meetings can be found on its website at the following address: https://ir.ufginsurance.com/events-and-presentations/event-calendar. About UFG Founded in 1946 as United Fire & Casualty Company, UFG, through its insurance company subsidiaries, is engaged in the business of writing property and casualty insurance. Through our subsidiaries, we are licensed as a property and casualty insurer in 49 states, plus the District of Columbia, and we are represented by approximately 1,000 independent agencies. A.M. Best Company assigns a rating of "A" (Excellent) for members of the United Fire & Casualty Group. For more information about UFG, visit www.ufginsurance.com or contact: Randy Patten, AVP and Controller, 319-286-2537 or IR@unitedfiregroup.com
Isiah Kiner-Falefa has always been a shortstop, but first had to fake his confidence as a catcher and a third baseman for the Texas Rangers. After winning a Gold Glove as a third baseman last season, Kiner-Falefa feels like he can finally be himself, and the leader for a rebuilding team, as their starting shortstop. “Third base isn’t who I am. It’s what I did,” Kiner-Falefa said.
The Goodison club are two points off the Champions League places after beating Southampton.
ST. JOHN'S, N.L. — Rough estimates from Newfoundland and Labrador's elections authority indicate it could be April before a winner is declared in the province's chaotic pandemic vote — almost two months after the original election day. Elections NL spokeswoman Adrienne Luther said Monday she expected her office will begin counting votes later this week, and last election's experience indicates it could take a while. "There's no easy way to estimate a date of conclusion because it's entirely dependent on how many (mail-in ballots) we get back," Luther said in an email. The provincial election was derailed in February by an outbreak of COVID-19 in the St. John's metro region. Voting day was Feb. 13, but less than 12 hours before the polls opened, Elections NL cancelled all in-person voting after health authorities announced a provincewide lockdown. Mail-in ballots must be postmarked by March 12 in order to count. Mail-in ballots take a lot of time, Luther said. Elections NL staff must verify the name and address of each ballot, she added. On average, her office opened and processed about 5,000 mail-in votes a day during the 2019 election, she said. "An estimate right now is that it will take approximately 20 straight days — we will be working full weekends — to do around 100,000 votes," Luther said. And that's on top of the 68,000 ballots that are already in the Elections NL office waiting to be counted, she said. Those ballots were cast before the outbreak upended the election and chief electoral officer Bruce Chaulk has said there are at least 12,000 mail-in ballots among them. Luther's office anticipates about 120,000 people requested a mail-in ballot before the Feb. 19 deadline. Some of those may have requested ballots for several people in a household, and some may not be returned at all. "Historically, we have had a very high rate of return on (mail-in ballots) but this election has been anything but predictable," Luther said. If Elections NL maintains its rate of counting about 5,000 ballots a day, then it will take at least 24 days to count 120,000 ballots, not including the ballots received before the vote was delayed. That means residents of the province could have to wait until April to learn who won the election. In the meantime, Chaulk is finalizing the process and protocols for scrutineers to oversee the process, Luther said. "At this point," she said, "one scrutineer per party will be permitted in the building where counting will take place." Liberal Leader and incumbent Premier Andrew Furey, who called the election on Jan. 15, has said in previous interviews his government will remain in "caretaker mode" until someone is declared the winner. This report by The Canadian Press was first published March 1, 2021. Sarah Smellie, The Canadian Press